ELEKTA ACQUIRES 3D LINE MEDICAL SYSTEMS

ELEKTA ACQUIRES 3D LINE MEDICAL SYSTEMS

PRESS RELEASE	
Stockholm, March 23, 2007

Elekta, world leader in advanced radiation therapy, comprehensive cancer
management and non-invasive treatment of brain disorders, today announced the
acquisition of 3D Line Medical Systems S.r.l. Through this acquisition, Elekta
adds a highly qualified R&D group specialized in stereotactic radiosurgery and
dynamic IMRT treatments as well as a product portfolio of advanced equipment and
treatment planning software systems for performing radiation therapy with
extreme precision and optimized dose distribution.

Subject to customary closing conditions, Elekta will pay EUR 10 M in cash for
assets in 3D Line Medical Systems (3D Line) related to radiation therapy and up
to a maximum of EUR 8 M, based on future performance over the coming 3 years.
Elekta expects to consolidate 3D Line into its accounts from May 1, 2007.

3D Line was founded in Italy in 1991 by the neurosurgeon Prof. Cesare Giorgi and
three computer scientists Davide Casolino, Marco Luzzara and Enrico Ongania. The
company has 35 employees and consultants, of whom most are based in Milan,
Italy. Among the 3D Line technologies commercially available today, are the
ERGO++, a specialized treatment planning system for stereotactic radiation
therapy and dynamic IMRT and also the DYNART™ series of micro-sized multi leaf
collimators. In 2006, 3D Line's net sales totaled EUR 6 M with a moderate
profit. 

“3D Line is one of the world's most innovative and competent companies in
supplying hardware and software for linear accelerator based stereotactic
radiosurgery and dynamic IMRT treatment and we see a strong potential in
becoming part of the Elekta Group, the pioneers of radiosurgery. The 3D Line
development team, with strong experience in highly sophisticated dynamic
treatments, will be able to further enhance Elekta's product portfolio both
through the current products and by the planned joint development”, commented
the founders of 3D Line during today's signing ceremony.

Building on the success and proven clinical benefits of image guided radiation
therapy (IGRT), there is an increasing market demand for complete stereotactic
add-on solutions, both from users who want to start a stereotactic program on
limited basis and from users who want to ensure that they have a fully
multifunctional linear accelerator system which could also be used for the most
advanced treatments.

Already integrated in Elekta Axesse™, the most advanced robotic image guided
stereotactic treatment management system from Elekta, 3D Line technology will
form a platform for further integration and development to meet the demand from
advanced radiation oncology programs for integrated, open architecture solutions
for enhancing precision and accuracy in radiation therapy. 

“3D Line's current products as well as the R&D pipeline fit extremely well into
the Elekta Group and the acquisition is an important step in the further
advancement of radiation therapy”, says Tomas Puusepp, President and CEO of
Elekta. “3D Line's cutting edge technology for dynamic beam shaping, arc
treatment and stereotactic treatment planning is an excellent addition to
Elekta's world-leading solutions for advanced radiation therapy and with the
increased global sales reach within Elekta, we will be able to exploit the
increasing demand for these products”, Tomas Puusepp concludes.

Roberto Pellegrini, CEO of 3D Line Medical Systems, says: “The strong synergies
between 3D Line and the Elekta Group both in radiation therapy and radiosurgery
warrants a successful future of the whole team. The highly motivated and
creative Italian spirit of 3D Line has always given rise to alternative and
unsurpassed solutions; the combination with the high technology always promoted
by Elekta has already started to generate unique solutions, to the benefits of
physicians and patients all over the world”, Roberto Pellegrini concludes.


******

For further information, please contact:


Peter Ejemyr
Group VP Corporate Communications, Elekta AB
Tel: +46 733 611 000
e-mail: peter.ejemyr@elekta.com 

About Elekta

Elekta is an international medical-technology Group, providing meaningful
clinical solutions, comprehensive information systems and services for improved
cancer care and management of brain disorders. All of Elekta's solutions employ
non-invasive or minimally invasive techniques and are therefore clinically
effective, gentle on the patient and cost-effective. 

Clinical solutions include among others Leksell Gamma Knife® for non-invasive
treatment of brain disorders and Elekta Synergy® for image guided radiation
therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April
2005, the Elekta Group is the world's largest supplier of oncology software. 

Elekta's systems and solutions are used at over 4,000 hospitals around the world
to treat cancer and manage clinical operations as well as to diagnose and treat
brain disorders, including tumors, vascular malformations and functional
disorders. 

With approx. 2,000 employees, Elekta's corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange
under the ticker EKTAb. For more information about Elekta, please visit
www.elekta.com and for more information about IMPAC Medical System please visit
www.impac.com.